Table 2.
# | Epi | |
---|---|---|
Fgfr2+/+; Pdgfra+/+ | 11 | 1.3 ± 0.4 |
Fgfr2+/+; Pdgfra−/− | 4 | 1.8 ± 0.6 |
Fgfr2−/−; Pdgfra+/− | 11 | 2.1 ± 0.7 |
Fgfr2+/−; Pdgfra−/− | 11 | 2.4 ± 0.6 |
Fgfr2−/−; Pdgfra−/− | 4 | 2.8 ± 0.3 |
# | Epi | |
---|---|---|
Fgfr2+/+; Pdgfra+/+ | 11 | 1.3 ± 0.4 |
Fgfr2+/+; Pdgfra−/− | 4 | 1.8 ± 0.6 |
Fgfr2−/−; Pdgfra+/− | 11 | 2.1 ± 0.7 |
Fgfr2+/−; Pdgfra−/− | 11 | 2.4 ± 0.6 |
Fgfr2−/−; Pdgfra−/− | 4 | 2.8 ± 0.3 |